TWiV 865: COVID-19 clinical update #101 with Dr. Daniel Griffin

February 12, 2022

In COVID-19 clinical update #101, Daniel Griffin discusses children and COVID, human challenge study results, effectiveness of mask use, Omicron boost in macaques, mucosal vaccine candidate, long-term cardiovascular outcomes, and global vaccine perceptions.

Click arrow to play
Download TWiV 865 (58 MB .mp3, 48 min)
Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

3 comments on “TWiV 865: COVID-19 clinical update #101 with Dr. Daniel Griffin

  1. Elise Leonard Feb 12, 2022

    Hi! Thanks as always for the great teaching! Did you guys see this preprint about an unadjuvanted spike protein nasal booster given to mice who had already had an mRNA vaccine? They got ‘robust protective mucosal immunity’. It seems like a wicked cool idea if it would work in people.

  2. Since there is no easy way to post comments on TWiM, I post this here: I think the last TWiM episode has made it accidentally into the TWiV feed. I don’t mind since I listen to all the podcasts anyway, but some people might be confused.

  3. Dawn PA Feb 14, 2022

    Thank you for sharing your knowledge every week, This has been immensely helpful and comforting during these times, My young child was treated for Kawasakis disease in April 2020 the diagnosis is now Kawaski’s versus MISC as our whole family were ill in February 2020 and we had a known exposure to COVID in that time period.
    Our family were delighted when the vaccine became available to children and continue to be hopeful as evidence is emerging it may also reduce the incidence of MISC. It’s been difficult to get info about this condition.
    I’m enjoying listening to older episodes too. Although I’m taking a break from nursing this info will be useful if I return.
    Thank you